• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconCOVID-19 vaccines

COVID-19 vaccines

Page 89 of 95
Map: 4 states have reached more than 10% of their populations with the vaccine
Health
Map: 4 states have reached more than 10% of their populations with the vaccine
By Erika Fry and Nicolas RappFebruary 3, 2021
What happened at Fortune’s not-in-Davos gathering of business leaders
Leadership
What happened at Fortune’s not-in-Davos gathering of business leaders
By Fortune EditorsFebruary 3, 2021
A man getting an injection.
Health
The AstraZeneca vaccine cuts COVID transmission—and delaying the second dose is a good idea, study finds
By Jeremy KahnFebruary 3, 2021
CNV.0321.Albert Bourla-featured
Magazine
Pfizer’s CEO thinks a vaccine-resistant COVID variant is ‘likely’—but that’s not as scary as it sounds
By Clifton LeafFebruary 3, 2021
Russia’s Sputnik V vaccine shows 91.6% efficacy rate, peer-reviewed findings say
Health
Russia’s Sputnik V vaccine shows 91.6% efficacy rate, peer-reviewed findings say
By Yuliya Fedorinova, Stepan Kravchenko and BloombergFebruary 2, 2021
Johnson & Johnson’s lower-immunity single-dose COVID vaccine might be just what the doctor ordered
Health
Johnson & Johnson’s lower-immunity single-dose COVID vaccine might be just what the doctor ordered
By Kat EschnerFebruary 1, 2021
01 February 2021, Lower Saxony, Lingen: Senior citizen Maria Hesemann-Peters is vaccinated against the corona virus with the active ingredient from Biontech/Pfizer by emergency paramedic Bernd Rode from the DRK (German Red Cross) at the vaccination centre in the Emslandhallen.
Health
Why Europe’s summer COVID vaccination target could still be on track
By David MeyerFebruary 1, 2021
How vaccine nationalism could extend the pandemic
Health
How vaccine nationalism could extend the pandemic
By James Paton and BloombergJanuary 31, 2021
President Biden Delivers Remarks On His Racial Equity Agenda And Signs Executive Actions
Politics
Joe Biden’s cabinet: What you need to know about the President’s key advisers and their top priorities
By Nicole GoodkindJanuary 31, 2021
Tom Richmond receives his AstraZeneca/Oxford University Covid-19 vaccine from Vaccinator Louise Chadwick at Acklam Road pharmacy on January 28, 2021 in Middlesbrough, England.
Health
With supplies running low, Europe approves AstraZeneca’s COVID-19 vaccine for all adults
By Jeremy Kahn and David MeyerJanuary 29, 2021
The 3 major fixes broken health systems need, according to experts
Health
The 3 major fixes broken health systems need, according to experts
By Erika FryJanuary 29, 2021
Johnson & Johnson’s single-dose COVID-19 vaccine is 66% effective, lagging rivals
Politics
Johnson & Johnson’s single-dose COVID-19 vaccine is 66% effective, lagging rivals
By The Associated PressJanuary 29, 2021
Pascal Soriot, chief executive officer of AstraZeneca Plc, listens during a Senate Finance Committee hearing on drug pricing on Capitol Hill in Washington, D.C., U.S., on Tuesday, Feb. 26, 2019.
Health
Germany may not use AstraZeneca’s vaccine for over-65s, as experts debate lack of data
By Jeremy Kahn and David MeyerJanuary 28, 2021
Valneva-Covid19 Vaccine
Health
France’s Valneva starts making COVID-19 vaccine in Scotland, ahead of trial results and approval
By David MeyerJanuary 28, 2021
State-by-state COVID vaccine rates: Idaho and Missouri are in last place
Health
State-by-state COVID vaccine rates: Idaho and Missouri are in last place
By Erika Fry and Nicolas RappJanuary 27, 2021
1...
  • 87
  • 88
  • 89
  • 90
  • 91
...95
Most Popular
Success
After donating $8 billion, Steve and Connie Ballmer create three regional philanthropies so people closest to the work can decide how the money is spentplaceholder alt text
By Sydney LakeAugust 11, 2026
Economy
U.S. Treasury is paying $3 billion a day in interest on national debt, says the CBO—having spent $10 billion to prop up the currency of its top lenderplaceholder alt text
By Eleanor PringleAugust 11, 2026
North America
Google cofounder Sergey Brin has now spent $100 million to fight California’s proposed billionaire tax—he could owe $13 billion if he losesplaceholder alt text
By Sasha RogelbergAugust 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.